Market Cap ₹7 Cr.
Stock P/E 34.9
P/B 0.4
Current Price ₹1.9
Book Value ₹ 4.6
Face Value 10
52W High ₹2.3
Dividend Yield 0%
52W Low ₹ 1.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Expenditure | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Profit | -0 | 0 | -0 | -1 | -0 | -0 | -0 | -0 | -0 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -0 | 0 | -0 | -1 | -0 | -0 | -0 | -0 | -0 | 0 |
Provision for Tax | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | -0 | 0 | -0 | -2 | -0 | -0 | -0 | -0 | -0 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | -0 | 0 | -0 | -2 | -0 | -0 | -0 | -0 | -0 | 0 |
Adjusted Earnings Per Share | -0 | 0.1 | -0 | -0.6 | -0 | -0 | -0 | -0 | -0 | 0.1 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 0 | 0 | 0 |
Other Income | 1 | 1 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 1 | 1 | 2 | 2 | 2 | 5 | 6 | 0 | 0 | 0 | 0 | 0 |
Total Expenditure | 0 | 10 | 1 | 1 | 0 | 3 | 9 | 0 | 7 | 1 | 0 | 0 |
Operating Profit | 0 | -9 | 1 | 1 | 2 | 2 | -3 | -0 | -7 | -1 | -0 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | -0 | 0 |
Profit Before Tax | 0 | -9 | 1 | 1 | 2 | 2 | -3 | -0 | 1 | -1 | -0 | 0 |
Provision for Tax | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Profit After Tax | 0 | -9 | 1 | 1 | 1 | 2 | -3 | -0 | 1 | -2 | -0 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | -9 | 1 | 1 | 1 | 2 | -3 | -0 | 1 | -2 | -0 | 0 |
Adjusted Earnings Per Share | 0.1 | -2.8 | 0.2 | 0.3 | 0.4 | 0.5 | -0.8 | -0.1 | 0.2 | -0.5 | -0 | 0.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 0% | -100% | 0% |
Operating Profit CAGR | 0% | 0% | -100% | 0% |
PAT CAGR | 0% | 0% | -100% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 10% | 30% | 6% | -19% |
ROE Average | -1% | -2% | -5% | -16% |
ROCE Average | -1% | -1% | -2% | -4% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 5 | 4 | 16 | 17 | 18 | 20 | 17 | 17 | 18 | 16 | 16 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 10 | 10 | 10 | 10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | -0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | 0 | 0 |
Total Current Liabilities | 2 | 2 | 3 | 2 | 3 | 21 | 13 | 12 | 4 | 4 | 4 |
Total Liabilities | 17 | 16 | 29 | 29 | 31 | 41 | 30 | 29 | 21 | 20 | 20 |
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 17 | 16 | 28 | 29 | 28 | 2 | 0 | 1 | 1 | 1 | 1 |
Total Current Assets | 0 | 1 | 1 | 1 | 3 | 39 | 30 | 28 | 21 | 19 | 19 |
Total Assets | 17 | 16 | 29 | 29 | 31 | 41 | 30 | 29 | 21 | 20 | 20 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | -0 | -10 | -2 | -1 | -2 | -2 | -1 | 0 | 8 | -2 | -0 |
Cash Flow from Investing Activities | -17 | 3 | -10 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
Cash Flow from Financing Activities | 17 | 7 | 12 | -1 | 0 | -0 | -0 | -0 | -8 | 2 | 0 |
Net Cash Inflow / Outflow | 0 | 0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | 0 | -0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.11 | -2.84 | 0.23 | 0.28 | 0.43 | 0.46 | -0.8 | -0.09 | 0.23 | -0.52 | -0.05 |
CEPS(Rs) | 0.12 | -2.84 | 0.23 | 0.28 | 0.43 | 0.46 | -0.8 | -0.09 | 0.23 | -0.52 | -0.05 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 2.38 | 1.33 | 4.57 | 4.85 | 5.28 | 5.75 | 4.95 | 4.86 | 5.09 | 4.56 | 4.52 |
Core EBITDA Margin(%) | 0 | 0 | 0 | 0 | 0 | -6.95 | -57.99 | 0 | 0 | 0 | 0 |
EBIT Margin(%) | 0 | 0 | 0 | 0 | 0 | 56.25 | -50.06 | 0 | 0 | 0 | 0 |
Pre Tax Margin(%) | 0 | 0 | 0 | 0 | 0 | 56.18 | -50.39 | 0 | 0 | 0 | 0 |
PAT Margin (%) | 0 | 0 | 0 | 0 | 0 | 56.18 | -50.39 | 0 | 0 | 0 | 0 |
Cash Profit Margin (%) | 0 | 0 | 0 | 0 | 0 | 56.18 | -50.39 | 0 | 0 | 0 | 0 |
ROA(%) | 3.03 | -50.52 | 3.52 | 3.4 | 4.94 | 4.49 | -7.88 | -1.09 | 3.21 | -8.85 | -0.8 |
ROE(%) | 0 | -180.11 | 8 | 6.04 | 8.45 | 8.41 | -14.91 | -1.87 | 4.62 | -10.87 | -1.01 |
ROCE(%) | 4.56 | -52.02 | 4.46 | 3.84 | 5.13 | 5.17 | -9.03 | -0.8 | 3.58 | -4.85 | -0.82 |
Receivable days | 0 | 0 | 0 | 0 | 0 | 365 | 222 | 0 | 0 | 0 | 0 |
Inventory Days | 0 | 0 | 0 | 0 | 0 | 1084.5 | 704.02 | 0 | 0 | 0 | 0 |
Payable days | 0 | 0 | 0 | 0 | -44.33 | -157.82 | 265.04 | 0 | 27.8 | 0 | 0 |
PER(x) | 0 | 0 | 0 | 722.93 | 374.25 | 8.86 | 0 | 0 | 3.7 | 0 | 0 |
Price/Book(x) | 0 | 6.28 | 0 | 42.36 | 30.35 | 0.72 | 0.29 | 0.06 | 0.17 | 0.62 | 0.37 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0 | 0 | 0 | 0 | 0 | 9.14 | 3.05 | 0 | 0 | 0 | 0 |
EV/Core EBITDA(x) | 93.17 | -4.32 | 47.61 | 662.8 | 375 | 16.24 | -6.08 | -54.08 | -0.89 | -13.72 | -84.09 |
Net Sales Growth(%) | 0 | 0 | 0 | 0 | 0 | 0 | 91.59 | -100 | 0 | 0 | 0 |
EBIT Growth(%) | 416.68 | -2426.71 | 111.64 | 10.67 | 38.59 | 6.35 | -270.52 | 91.69 | 486.66 | -211.23 | 83.85 |
PAT Growth(%) | 271.91 | -3332.43 | 109.36 | 24.3 | 50.61 | 8.3 | -271.85 | 88.52 | 351.14 | -328.19 | 91.26 |
EPS Growth(%) | -19.03 | -2570.84 | 108.06 | 24.3 | 50.61 | 8.3 | -271.84 | 88.52 | 351.15 | -328.2 | 91.27 |
Debt/Equity(x) | 2.07 | 3 | 0.79 | 0.7 | 0.66 | 0.6 | 0.69 | 0.68 | 0.19 | 0.23 | 0.24 |
Current Ratio(x) | 0.03 | 0.28 | 0.42 | 0.35 | 1.25 | 1.81 | 2.25 | 2.25 | 4.76 | 4.81 | 4.69 |
Quick Ratio(x) | 0.03 | 0.28 | 0.43 | 0.38 | 0.11 | 1.15 | 1.71 | 1.67 | 4.73 | 4.77 | 4.65 |
Interest Cover(x) | 56.13 | 0 | 203.79 | 1386.98 | 1192.59 | 857.2 | -151.81 | -2.56 | 10.34 | -11.24 | -318.8 |
Total Debt/Mcap(x) | 0 | 0.48 | 0 | 0.02 | 0.02 | 0.84 | 2.4 | 11.72 | 1.16 | 0.36 | 0.64 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 9.43 | 9.43 | 9.43 | 9.43 | 9.43 | 9.43 | 9.43 | 9.43 | 9.43 | 9.43 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 90.57 | 90.57 | 90.57 | 90.57 | 90.57 | 90.57 | 90.57 | 90.57 | 90.57 | 90.57 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About